Clearline Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-41,334
Closed -$689K 65
2016
Q4
$689K Buy
+41,334
New +$689K 0.31% 37